Donald Trump Jr. has joined billionaire entrepreneur Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren ...

That being said, we’re here with a list of the 12 best Fortune 500 stocks to buy according to billionaires. We began by ...

The Acuvue Oasys Max 1-Day Multifocal marks the first and only daily disposable contact lens to be available for people with ...

Johnson & Johnson today announced it launched its Acuvue Oasys Max multifocal lens for patients with both astigmatism and ...

Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform for autologous CAR-T cell manufacturing.

Per ODAC and CHMP recommendations, subcutaneous daratumumab may become the first approved treatment for smoldering myeloma.

Protagonist Therapeutics' partners ought to secure two approvals for blockbuster drugs within the next year. Click here to ...

Johnson & Johnson MedTech announced today that it launched new variable angle optimized locking technology (VOLT) plating ...

In terms of liquidity and interest, the mean open interest for Johnson & Johnson options trades today is 3709.43 with a total volume of 4,332.00.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

The dry AMD treatment market is experiencing unprecedented growth, driven by increasing disease awareness, rising prevalence of age-related eye cond ...